These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20237501

  • 1. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
    Konrad T, Franke S, Schneider F, Bär F, Vetter G, Winkler K.
    J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A.
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA, Renauld A, Akopian M, Olivieri AO, Garrido D.
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.
    Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, Fallo F.
    Am J Hypertens; 2005 Jan; 18(1):30-5. PubMed ID: 15691614
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH, Jørgensen CG, Mulvany MJ, Sørensen KE.
    Blood Press; 2007 Jan; 16(2):106-13. PubMed ID: 17612909
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance and blood pressure circadian variation in an obese hypertensive population.
    Diamantopoulos EJ, Andreadis E, Tsourous G, Katsanou P, Georgiopoulos D, Fotia M, Antoniou A, Raptis SA.
    Clin Exp Hypertens; 2006 Oct; 28(7):625-30. PubMed ID: 17060061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.